Legal Disclaimer
You are responsible for reading, understanding and agreeing to the National Law Review s (NLR’s) and the National Law Forum LLC s Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.
Critical vulnerability found in Snow Software s Inventory Agent computing.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from computing.co.uk Daily Mail and Mail on Sunday newspapers.
(1)
Circulating cell-free mRNA in blood reflective of NAFLD/NASH liver pathology
PALO ALTO, Calif., Feb. 23, 2021 /PRNewswire/ Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of its human proof-of-concept study describing the stratification of NAFLD/NASH patients with clinically relevant and advanced liver fibrosis using the company s Next-Generation cell-free mRNA Liquid Biopsy Technology Platform. The study titled Non-invasive Stratification of Non-Alcoholic Fatty Liver Disease by Whole-transcriptome Cell-free mRNA Characterization was published in the
American Journal of Physiology -
Gastrointestinal and Liver Physiology, a journal of the American Physiological Society. The first author is Naga Chalasani, M.D., Professor of Gastroenterology and Hepatology and Interim Chair in the Department of Medicine at Indiana University in the USA. Dr. Chalasani is the leading author of the AASLD Practice Guidelines for the diagnosis and
Simplify compliance and manage risk with Microsoft Compliance Manager Hafid Elabdellaoui Chief Security Advisor, CSG ESA Share
The cost of non-compliance is more than twice that of compliance costs. Non-compliance with the ever-increasing and changing regulatory requirements can have a significant impact on your organization’s brand, reputation, and revenue. According to a study by the Ponemon Institute and Globalscape
, being compliant will cost you less compared to business disruptions, loss of revenue, and hefty fines.
Data explosion and regulatory environment
As organizations go through digital transformation, they are generating and consuming much more data than in the past to help them gain an edge over their competitors. This data is necessary to continue to stay relevant by empowering employees, engaging customers, and optimizing operations. Managing this data and the variety of devices on which it is created can be complicated, especially when it